1. Volpe, JJ. Neonatal seizures In Volpe Neurology of the Newborn, 4th ed. Philadelphia: WB Sanders, 2000, p. 129–159.
2. Mizrahi, EM. Neonatal seizures In Swaiman, KF., Ashwai, S. Pediatric neurology principles and practice, 4th ed. Mosby-Elsevier, 2006, p. 257–277.
3. Lanska, MJ., et al. A population based study of neonatal seizures in Tayette count, Kentucky. Neurology, 1995, 45, p. 724.
4. Kohelet, D., et al. Risk factors for neonatal seizures in very low birth infants: population based survey. J Child Neurol, 2004, 19, 2, p. 123–128.
5. Scher, MS., et al. Electrographic seizures in preterm and fullterm neonates: clinical correlates, associated brain lessions and risk for neurologic sequale. Pediatrics, 1993, 91, 1, p. 128–134.
6. Brunquell, PJ., et al. Prediction of outcome based on clinical seizure type in newborn infants. J Pediatr, 2002, 140, p. 707–712.
7. Tekgul, H., et al. The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics, 2006, 117, 4, p. 1270–1280.
8. Sankar, R. Neonatal seizures, after all these years we still love what doesnt work. Neurology, 2005, 64, p. 776–777.
9. Levene, M. The clinical conundrum of neonatal seizures. Arch Dis Child Fetal Neonatal Ed, 2002, 86, p. F75–F77.
10. Boylan, GB. Phenobarbitone, neonatal seizures and video-EEG. Arch Dis Child Fetal Neonatal Ed, 2002, 86, p. F165–170.
11. Schubert, S. Neuroprotective effects of topiramate after hypoxia-ischemia in newborn piglets. Brain Res, 2005, 1058,
1–2, p. 129–136.
12. Castro Conde, JR. Midazolam in neonatal seizures with no res-ponse to phenobarbital. Neurology, 2005, 64, p. 876–879.